Babam2 - BRISC and BRCA1 A complex member 2 Gene
Also Known as Bre; 6030405P19Rik; B830038C02Rik
Species: Mus musculus
Summary
Enables tumor necrosis factor receptor binding activity. Predicted to be involved in several processes, including mitotic G2 DNA damage checkpoint signaling; positive regulation of DNA repair; and response to ionizing radiation. Predicted to act upstream of or within several processes, including DNA repair; apoptotic process; and chromatin organization. Predicted to be located in cytosol and nucleus. Predicted to be part of BRCA1-A complex; BRISC complex; and nuclear ubiquitin Ligase complex. Is expressed in central nervous system and retina. Orthologous to human BABAM2 (BRISC and BRCA1 A complex member 2). [provided by Alliance of Genome Resources, Apr 2022]
Babam2 Products (5)
| mRNA | Protein | Name |
|---|---|---|
| NM_144541.1 | NP_653124.1 | BRISC and BRCA1-A complex member 2 isoform V |
| NM_181279.1 | NP_851796.1 | BRISC and BRCA1-A complex member 2 isoform I |
| NM_181280.1 | NP_851797.1 | BRISC and BRCA1-A complex member 2 isoform IV |
| NM_181281.1 | NP_851798.1 | BRISC and BRCA1-A complex member 2 isoform III |
| NM_181282.1 | NP_851799.1 | BRISC and BRCA1-A complex member 2 isoform II |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables tumor necrosis factor receptor binding |
IDA
IDA: Inferred from direct assay
|
9737713 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
BRISC and BRCA1-A complex member 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS01332 | BABAM2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service